MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
NCT 05462236 Brief Summary The study is a 2-part study of Tinodasertib…
Read more arrow_forwardNCT 05462236 Brief Summary The study is a 2-part study of Tinodasertib…
Read more arrow_forwardNCT 02645149 Brief Summary This is a patient oriented translational research project…
Read more arrow_forwardACTRN 12623000902695 Brief Summary This study is investigating the feasibility, safety and…
Read more arrow_forwardACTRN 12619000288123 Brief Introduction This study aims to evaluate the safety and…
Read more arrow_forwardNCT 05024318 Brief Summary This is a prospective, open label, phase II,…
Read more arrow_forwardNCT 05025813 Brief Summary Cutaneous Squamous Cell Carcinoma (cSCC) is typically associated…
Read more arrow_forwardACTRN 12620001286932 Brief Summary The purpose of this study is to learn…
Read more arrow_forwardACTRN 12621001529831 Brief Summary This trial is for patients with primary mediastinal…
Read more arrow_forwardACTRN 12623000620628 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardACTRN 12623000552684 Brief Summary The purpose of this study is to investigate…
Read more arrow_forward